Sinovac Biotech (SVA) Reports Q4 EPS of $0.01

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. LEVI
3. SBUX
4. NVDA
5. AAPL
6. GOOGL
7. ORCL
8. SPY
9. APLD
10. USO

Go back to Sinovac Biotech (SVA) Reports Q4 EPS of $0.01

Sinovac Reports Unaudited Fourth Quarter and Full Year 2015 Financial Results

April 5, 2016 6:16 AM EDT

BEIJING, April 5, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and twelve month financial results for the period ended December 31, 2015.

Fourth Quarter 2015 Financial Highlights(compared to the fourth quarter of 2014)

Quarterly sales from continuing operations were $23.0million, an increase of 13.1% from $20.3 million in the prior year period. Gross profit from continuing operations was $15.7million, an increase of 2.3% from $15.3million in the prior year period. Gross margin was 68.3%, compared to... More